UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10‐year Japanese postmarketing surveillance data

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.50-58

2017

Volltextzugriff (PDF)

A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.59-66

2017

Volltextzugriff (PDF)

A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-11, Vol.19 (6), p.853-860

2013

Volltextzugriff (PDF)

Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors-phase I trial: 2nd report

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-03, Vol.19 (2), p.330-337

2013

Volltextzugriff (PDF)

An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.771-776

2011

Volltextzugriff (PDF)

Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors - Phase I trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-01, Vol.18 (1), p.94-101

2012

Volltextzugriff (PDF)

Current status and future prospects of AIDS core hospitals in Japan

International journal of infectious diseases, 2018-08, Vol.73, p.243-243

2018

Volltextzugriff (PDF)

Sequential assessment of cardiac function after CART therapy in accordance with the grade of CRS

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

The correlation between cardiac biomarkers and serum cytokines after CAR-T therapy

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Experimental evidence of effective human–AI collaboration in medical decision-making

Scientific reports, 2022-09, Vol.12 (1), p.14952-10, Article 14952

2022

Volltextzugriff (PDF)

Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients

AIDS (London), 2005-06, Vol.19 (9), p.879-886

2005

Volltextzugriff (PDF)

Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura

The New England journal of medicine, 2024-05, Vol.390 (17), p.1584-1596

2024

Volltextzugriff (PDF)

Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation

Bone marrow transplantation (Basingstoke), 2002, Vol.29 (2), p.107-111

2002

Volltextzugriff (PDF)

OC 06.3 Final Analysis Results from a Phase Iii Study of Emicizumab Prophylaxis for Acquired Hemophilia A (AGEHA)

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100406, Article 100406

2023

Volltextzugriff (PDF)

Clinical features of 32 new Japanese cases with autoimmune haemorrha-philia due to anti-factor XIII antibodies

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-09, Vol.21 (5), p.653-658

2015

Volltextzugriff (PDF)

A phase III clinical trial of a mixture agent of plasma‐derived factor VII a and factor X ( MC 710) in haemophilia patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.59-66

2017

Volltextzugriff (PDF)

Factor IX and factor IX inhibitor

Nihon rinshō, 1999-09, Vol.57 Suppl, p.611

1999

Volltextzugriff (PDF)

40K glycoPEGylated, recombinant FVIIa: 3‐month, double‐blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors

Journal of thrombosis and haemostasis, 2013-07, Vol.11 (7), p.1260-1268

2013

Volltextzugriff (PDF)

Vitamin C activity of dehydroascorbic acid in humans: Association between changes in the blood vitamin C concentration or urinary excretion after oral loading

Journal of Nutritional Science and Vitaminology, 2008, Vol.54(4), pp.315-320

2008

Volltextzugriff (PDF)

Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus

Thrombosis research, 2002-09, Vol.107 (6), p.319-323

2002

Volltextzugriff (PDF)

As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan

Thrombosis and haemostasis, 2011-05, Vol.105 (5), p.925-927

2011

Volltextzugriff (PDF)

Polymorphism of glutathione S-transferase P1 gene affects human vitamin C metabolism

Biochemical and biophysical research communications, 2007-12, Vol.364 (3), p.708-713

2007

Volltextzugriff (PDF)

Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial

Journal of thrombosis and haemostasis, 2012-01, Vol.10 (1), p.81-89

2012

Volltextzugriff (PDF)

Inhibitors of Factor XIII/13 in older patients

Seminars in thrombosis and hemostasis, 2014-09, Vol.40 (6), p.704-711

Ichinose, Akitada

2014

Volltextzugriff (PDF)

Factor IX inhibitor

Nihon rinshō, 1995-03, Vol.53 Su Pt 2, p.98

1995

Volltextzugriff (PDF)

1 – 25 von 457

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(249)
Mit Volltextzugriff
(315)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(188)
Life Sciences & Biomedicine
(157)
Humans
(136)
Male
(65)
Female
(59)
Adult
(51)
Biological And Medical Sciences
(45)
Middle Aged
(39)
Hematology
(38)
Biochemistry & Molecular Biology
(30)
Physical Sciences
(27)
Genetics & Heredity
(26)
Medical Sciences
(25)
Chemistry
(24)
Fundamental And Applied Biological Sciences. Psychology
(24)
Mutation
(24)
Aged
(22)
Japan
(22)
Animals
(20)
Genomes
(19)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(234)
MEDLINE
(161)
Ingenta
(109)
Journals@Ovid Full Text
(78)
Wiley Online Library
(51)
IngentaConnect Journals
(51)
Wiley Online Library
(46)
Publisher or Other Site
(41)
Access via ScienceDirect (Elsevier)
(39)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(30)
Oxford journals
(23)
SpringerLink
(20)
Nature Journals
(18)
Taylor & Francis Online
(16)
Taylor & Francis Journals
(14)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(13)
Taylor & Francis
(10)
IEEE Xplore
(8)
JSTOR
(7)
Oxford Journals 2020 Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10‐year Japanese postmarketing surveillance data

A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors

A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics

Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors-phase I trial: 2nd report

An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan

Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors - Phase I trial

Current status and future prospects of AIDS core hospitals in Japan

Sequential assessment of cardiac function after CART therapy in accordance with the grade of CRS

The correlation between cardiac biomarkers and serum cytokines after CAR-T therapy

Experimental evidence of effective human–AI collaboration in medical decision-making

Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients

Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura

Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation

OC 06.3 Final Analysis Results from a Phase Iii Study of Emicizumab Prophylaxis for Acquired Hemophilia A (AGEHA)

Clinical features of 32 new Japanese cases with autoimmune haemorrha-philia due to anti-factor XIII antibodies

A phase III clinical trial of a mixture agent of plasma‐derived factor VII a and factor X ( MC 710) in haemophilia patients with inhibitors

Factor IX and factor IX inhibitor

40K glycoPEGylated, recombinant FVIIa: 3‐month, double‐blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors

Vitamin C activity of dehydroascorbic acid in humans: Association between changes in the blood vitamin C concentration or urinary excretion after oral loading

Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus

As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan

Polymorphism of glutathione S-transferase P1 gene affects human vitamin C metabolism

Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial

Inhibitors of Factor XIII/13 in older patients

Factor IX inhibitor

Suchergebnisse filtern